Format
Sort by
Items per page

Send to

Choose Destination

Best matches for O’Neill WC[au]:

Imaging for Vascular Calcification. Raggi P et al. Semin Dial. (2017)

Renal relevant radiology: use of ultrasound in kidney disease and nephrology procedures. O'Neill WC et al. Clin J Am Soc Nephrol. (2014)

Point-of-care ultrasound in the practice of nephrology. Niyyar VD et al. Kidney Int. (2018)

Search results

Items: 1 to 50 of 108

1.

Retooling Nephrology with Ultrasound.

O'Neill WC, Ross DW.

Clin J Am Soc Nephrol. 2019 May 7;14(5):771-773. doi: 10.2215/CJN.10430818. Epub 2019 Mar 27. No abstract available.

PMID:
30917993
2.

Renal Hypertrophy in Liver Failure.

Saad M, Ellis CL, O'Neill WC.

Kidney Int Rep. 2018 Jul 6;3(6):1464-1467. doi: 10.1016/j.ekir.2018.07.004. eCollection 2018 Nov. No abstract available.

3.

Progression of Medial Arterial Calcification in CKD.

Manzoor S, Ahmed S, Ali A, Han KH, Sechopoulos I, O'Neill A, Fei B, O'Neill WC.

Kidney Int Rep. 2018 Jul 21;3(6):1328-1335. doi: 10.1016/j.ekir.2018.07.011. eCollection 2018 Nov.

4.

Questionable specificity of histologic findings in calcific uremic arteriolopathy.

Ellis CL, O'Neill WC.

Kidney Int. 2018 Aug;94(2):390-395. doi: 10.1016/j.kint.2018.03.016. Epub 2018 Jun 7.

PMID:
29885932
5.

Pyrophosphate deficiency in vascular calcification.

Villa-Bellosta R, O'Neill WC.

Kidney Int. 2018 Jun;93(6):1293-1297. doi: 10.1016/j.kint.2017.11.035. Epub 2018 Mar 24. Review.

PMID:
29580636
6.

Point-of-care ultrasound in the practice of nephrology.

Niyyar VD, O'Neill WC.

Kidney Int. 2018 May;93(5):1052-1059. doi: 10.1016/j.kint.2017.11.032. Epub 2018 Feb 22. Review.

PMID:
29477241
7.

Understanding the pathogenesis of vascular calcification: timing is everything.

O'Neill WC.

Kidney Int. 2017 Dec;92(6):1316-1318. doi: 10.1016/j.kint.2017.07.020.

PMID:
29153135
8.

Introduction to Imaging in Dialysis Patients.

O'Neill WC.

Semin Dial. 2017 Jul;30(4):289. doi: 10.1111/sdi.12606. Epub 2017 May 25. No abstract available.

PMID:
28547810
9.

Diagnosis and Management of Acquired Cystic Kidney Disease and Renal Tumors in ESRD Patients.

Rahbari-Oskoui F, O'Neill WC.

Semin Dial. 2017 Jul;30(4):373-379. doi: 10.1111/sdi.12605. Epub 2017 May 21. Review.

PMID:
28543535
10.

Imaging for Vascular Calcification.

Raggi P, O'Neill WC.

Semin Dial. 2017 Jul;30(4):347-352. doi: 10.1111/sdi.12596. Epub 2017 Mar 22. Review.

PMID:
28332217
11.

Persistence of Vascular Calcification after Reversal of Uremia.

Lomashvili KA, Manning KE, Weitzmann MN, Nelea V, McKee MD, O'Neill WC.

Am J Pathol. 2017 Feb;187(2):332-338. doi: 10.1016/j.ajpath.2016.10.006. Epub 2016 Dec 8.

12.

Increased Peripheral Arterial Calcification in Patients Receiving Warfarin.

Han KH, O'Neill WC.

J Am Heart Assoc. 2016 Jan 25;5(1). pii: e002665. doi: 10.1161/JAHA.115.002665.

13.

Targeting serum calcium in chronic kidney disease and end-stage renal disease: is normal too high?

O'Neill WC.

Kidney Int. 2016 Jan;89(1):40-5. doi: 10.1016/j.kint.2015.10.001. Review.

PMID:
26759046
14.

Acute and 3-month effects of calcium carbonate on the calcification propensity of serum and regulators of vascular calcification: secondary analysis of a randomized controlled trial.

Bristow SM, Gamble GD, Pasch A, O'Neill WC, Stewart A, Horne AM, Reid IR.

Osteoporos Int. 2016 Mar;27(3):1209-1216. doi: 10.1007/s00198-015-3372-y. Epub 2015 Oct 22.

PMID:
26493812
15.

The association of bone and osteoclasts with vascular calcification.

Han KH, Hennigar RA, O'Neill WC.

Vasc Med. 2015 Dec;20(6):527-33. doi: 10.1177/1358863X15597076. Epub 2015 Aug 31.

PMID:
26324151
16.

A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.

Bhutani H, Smith V, Rahbari-Oskoui F, Mittal A, Grantham JJ, Torres VE, Mrug M, Bae KT, Wu Z, Ge Y, Landslittel D, Gibbs P, O'Neill WC, Chapman AB; CRISP Investigators.

Kidney Int. 2015 Jul;88(1):146-51. doi: 10.1038/ki.2015.71. Epub 2015 Apr 1.

17.

Prevalence of nonatheromatous lesions in peripheral arterial disease.

O'Neill WC, Han KH, Schneider TM, Hennigar RA.

Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):439-47. doi: 10.1161/ATVBAHA.114.304764. Epub 2014 Dec 4.

PMID:
25477344
18.

Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification.

Sheen CR, Kuss P, Narisawa S, Yadav MC, Nigro J, Wang W, Chhea TN, Sergienko EA, Kapoor K, Jackson MR, Hoylaerts MF, Pinkerton AB, O'Neill WC, Millán JL.

J Bone Miner Res. 2015 May;30(5):824-36. doi: 10.1002/jbmr.2420.

19.

Increased vascular calcification in patients receiving warfarin.

Tantisattamo E, Han KH, O'Neill WC.

Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):237-42. doi: 10.1161/ATVBAHA.114.304392. Epub 2014 Oct 16.

PMID:
25324574
20.

The author replies.

O'Neill WC.

Kidney Int. 2014 Oct;86(4):858. doi: 10.1038/ki.2014.186. No abstract available.

21.

Renal resistive index: a case of mistaken identity.

O'Neill WC.

Hypertension. 2014 Nov;64(5):915-7. doi: 10.1161/HYPERTENSIONAHA.114.04183. Epub 2014 Aug 25. Review. No abstract available. Erratum in: Hypertension. 2015 Aug;66(2):e9.

PMID:
25156171
22.

The clinical significance of medial arterial calcification in end-stage renal disease in women.

Abou-Hassan N, Tantisattamo E, D'Orsi ET, O'Neill WC.

Kidney Int. 2015 Jan;87(1):195-9. doi: 10.1038/ki.2014.187. Epub 2014 May 28.

23.

Vascular calcification is dependent on plasma levels of pyrophosphate.

Lomashvili KA, Narisawa S, Millán JL, O'Neill WC.

Kidney Int. 2014 Jun;85(6):1351-6. doi: 10.1038/ki.2013.521. Epub 2014 Apr 9.

24.

Structure, not just function.

O'Neill WC.

Kidney Int. 2014 Mar;85(3):503-5. doi: 10.1038/ki.2013.426.

25.

Renal relevant radiology: use of ultrasound in kidney disease and nephrology procedures.

O'Neill WC.

Clin J Am Soc Nephrol. 2014 Feb;9(2):373-81. doi: 10.2215/CJN.03170313. Epub 2014 Jan 23. Review.

26.

Role of local versus systemic vitamin D receptors in vascular calcification.

Lomashvili KA, Wang X, O'Neill WC.

Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):146-51. doi: 10.1161/ATVBAHA.113.302525. Epub 2013 Nov 7.

PMID:
24202304
27.

Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation.

O'Neill WC, Adams AL.

Kidney Int. 2014 Mar;85(3):668-76. doi: 10.1038/ki.2013.351. Epub 2013 Sep 18.

28.

Sodium thiosulfate: mythical treatment for a mysterious disease?

O'Neill WC.

Clin J Am Soc Nephrol. 2013 Jul;8(7):1068-9. doi: 10.2215/CJN.04990513. Epub 2013 Jun 6. No abstract available.

29.

Using a filtration technique to isolate platelet free plasma for assaying pyrophosphate.

Tolouian R, Connery SM, O'Neill WC, Gupta A.

Clin Lab. 2012;58(11-12):1129-34.

30.

The risk for medial arterial calcification in CKD.

Hassan NA, D'Orsi ET, D'Orsi CJ, O'Neill WC.

Clin J Am Soc Nephrol. 2012 Feb;7(2):275-9. doi: 10.2215/CJN.06490711. Epub 2011 Dec 8.

31.

Imaging for renovascular disease.

O'Neill WC, Bardelli M, Yevzlin AS.

Semin Nephrol. 2011 May;31(3):272-82. doi: 10.1016/j.semnephrol.2011.05.007. Review.

PMID:
21784276
32.

The chemistry of thiosulfate and vascular calcification.

O'Neill WC, Hardcastle KI.

Nephrol Dial Transplant. 2012 Feb;27(2):521-6. doi: 10.1093/ndt/gfr375. Epub 2011 Jul 7.

33.

Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification.

Lomashvili KA, Wang X, Wallin R, O'Neill WC.

J Biol Chem. 2011 Aug 19;286(33):28715-22. doi: 10.1074/jbc.M111.251462. Epub 2011 Jun 24.

34.

Extracellular pyrophosphate metabolism and calcification in vascular smooth muscle.

Villa-Bellosta R, Wang X, Millán JL, Dubyak GR, O'Neill WC.

Am J Physiol Heart Circ Physiol. 2011 Jul;301(1):H61-8. doi: 10.1152/ajpheart.01020.2010. Epub 2011 Apr 13.

35.

Effect of medial calcification on vascular function in uremia.

Sutliff RL, Walp ER, El-Ali AM, Elkhatib S, Lomashvili KA, O'Neill WC.

Am J Physiol Renal Physiol. 2011 Jul;301(1):F78-83. doi: 10.1152/ajprenal.00533.2010. Epub 2011 Apr 6.

36.

A daunting task but largely successful in developing meaningful guidelines.

O'Neill WC.

Semin Dial. 2011 Jan-Feb;24(1):24-7. doi: 10.1111/j.1525-139X.2010.00822.x. Review. No abstract available.

PMID:
21338388
37.

Breast arterial calcification: a marker of medial vascular calcification in chronic kidney disease.

Duhn V, D'Orsi ET, Johnson S, D'Orsi CJ, Adams AL, O'Neill WC.

Clin J Am Soc Nephrol. 2011 Feb;6(2):377-82. doi: 10.2215/CJN.07190810. Epub 2011 Jan 21.

38.

Treatment with pyrophosphate inhibits uremic vascular calcification.

O'Neill WC, Lomashvili KA, Malluche HH, Faugere MC, Riser BL.

Kidney Int. 2011 Mar;79(5):512-7. doi: 10.1038/ki.2010.461. Epub 2010 Dec 1.

39.

Recent progress in the treatment of vascular calcification.

O'Neill WC, Lomashvili KA.

Kidney Int. 2010 Dec;78(12):1232-9. doi: 10.1038/ki.2010.334. Epub 2010 Sep 22. Review.

40.

Determinants and functional significance of renal parenchymal volume in adults.

Johnson S, Rishi R, Andone A, Khawandi W, Al-Said J, Gletsu-Miller N, Lin E, Baumgarten DA, O'Neill WC.

Clin J Am Soc Nephrol. 2011 Jan;6(1):70-6. doi: 10.2215/CJN.00030110. Epub 2010 Sep 16.

41.

Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia.

Prosdocimo DA, Wyler SC, Romani AM, O'Neill WC, Dubyak GR.

Am J Physiol Cell Physiol. 2010 Mar;298(3):C702-13. doi: 10.1152/ajpcell.00419.2009. Epub 2009 Dec 16.

42.

Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP).

Dahl R, Sergienko EA, Su Y, Mostofi YS, Yang L, Simao AM, Narisawa S, Brown B, Mangravita-Novo A, Vicchiarelli M, Smith LH, O'Neill WC, Millán JL, Cosford ND.

J Med Chem. 2009 Nov 12;52(21):6919-25. doi: 10.1021/jm900383s.

43.

Mineral complexes and vascular calcification.

O'Neill WC.

Kidney Int. 2009 Oct;76(8):915; author 915-6. doi: 10.1038/ki.2009.273. No abstract available.

44.

Application of ultrasound in nephrology practice.

Gosmanova EO, Wu S, O'Neill WC.

Adv Chronic Kidney Dis. 2009 Sep;16(5):396-404. doi: 10.1053/j.ackd.2009.07.001. Review.

PMID:
19695508
45.

Plasma pyrophosphate and vascular calcification in chronic kidney disease.

O'Neill WC, Sigrist MK, McIntyre CW.

Nephrol Dial Transplant. 2010 Jan;25(1):187-91. doi: 10.1093/ndt/gfp362. Epub 2009 Jul 24.

46.

Acute kidney injury in a patient with unilateral ureteral obstruction.

Gosmanova EO, Baumgarten DA, O'Neill WC.

Am J Kidney Dis. 2009 Oct;54(4):775-9. doi: 10.1053/j.ajkd.2009.03.028. Epub 2009 Jul 9. No abstract available.

PMID:
19592146
47.

Improving training in nephrology procedures: yes we can.

O'Neill WC.

Am J Kidney Dis. 2009 Jul;54(1):4-5. doi: 10.1053/j.ajkd.2009.03.001. No abstract available.

PMID:
19559335
48.

Response to 'On vascular calcification prevention with phosphonoformate and bisphosphonates'.

Lomashvili KA, O'Neill WC.

Kidney Int. 2009 Jun 2;75(12):1356. doi: 10.1038/ki.2009.113. Epub 2015 Oct 20. No abstract available.

49.

Autocrine ATP release coupled to extracellular pyrophosphate accumulation in vascular smooth muscle cells.

Prosdocimo DA, Douglas DC, Romani AM, O'Neill WC, Dubyak GR.

Am J Physiol Cell Physiol. 2009 Apr;296(4):C828-39. doi: 10.1152/ajpcell.00619.2008. Epub 2009 Feb 4.

50.

Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.

Lomashvili KA, Monier-Faugere MC, Wang X, Malluche HH, O'Neill WC.

Kidney Int. 2009 Mar;75(6):617-25. doi: 10.1038/ki.2008.646. Epub 2009 Jan 7.

Supplemental Content

Loading ...
Support Center